{"id":"W3173672649","doi":"10.1016/j.cgh.2021.06.037","title":"Clinical Decision Support Tool for Infliximab in Crohn’s Disease","year":2021,"lang":"en","type":"letter","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Vedolizumab; Infliximab; Ustekinumab; Crohn's disease; Clinical decision support system; Clinical trial; Disease; Intensive care medicine; Inflammatory bowel disease; Clinical Practice; Biologic Agents; Crohn disease; Internal medicine; Physical therapy; Decision support system; Artificial intelligence","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003419872,0.0005208806,0.001366206,0.002064692,0.001262067,0.004519563,0.001333587,0.0104925,0.01577841],"category_scores_gemma":[0.03666807,0.0004495193,0.001132248,0.001036845,0.001057312,0.002799122,0.001336482,0.0124129,0.008145874],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002177086,"about_ca_system_score_gemma":0.002576156,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001538742,"about_ca_topic_score_gemma":0.002526943,"domain_scores_codex":[0.9962593,0.001906852,0.0006328923,0.0001925919,0.0006703818,0.0003379393],"domain_scores_gemma":[0.9745222,0.01718166,0.001099308,0.0005906242,0.00307201,0.003534133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007047438,0.0001824604,0.007875568,0.0002090343,0.00006825107,0.01069823,0.0002722092,0.0008559373,0.0004180665,0.005872241,0.8732118,0.09963138],"study_design_scores_gemma":[0.001459705,0.0004071,0.008023154,0.001997811,0.000263383,0.02188921,0.0008197684,0.01686453,0.0010534,0.04558054,0.9014351,0.0002062712],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.005141829,0.004670052,0.002973564,0.9409313,0.01368248,0.0001632627,0.0005815158,0.0004777569,0.03137835],"genre_scores_gemma":[0.1630233,0.007911967,0.03537234,0.595798,0.1609815,0.0008626973,0.001926526,0.000328549,0.03379514],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01577841,"threshold_uncertainty_score":0.05278409,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02609728352573156,"score_gpt":0.3392933622047942,"score_spread":0.3131960786790626,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}